Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1526033
PUBLISHER: BCC Research | PRODUCT CODE: 1526033
Cell Therapy Biomanufacturing: Global Markets
PUBLISHED:
PAGES: 112 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global market for cell therapy biomanufacturing is expected to grow from $9.7 billion in 2024 and is projected to reach $16.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.5% during the forecast period of 2024 to 2029.
The global market for cell therapy biomanufacturing for type of therapy is expected to grow from $5.3 billion in 2024 and is projected to reach $8.6 billion by the end of 2029, at a CAGR of 10.2% during the forecast period of 2024 to 2029.
The global market for cell therapy biomanufacturing for sources of cells is expected to grow from $4.4 billion in 2024 and is projected to reach $8.1 billion by the end of 2029, at a CAGR of 13.0% during the forecast period of 2024 to 2029.
Report Scope:
This report discusses the key trends shaping the global cell therapy biomanufacturing market, exploring factors that drive or hinder growth while providing valuable insights for stakeholders and potential newcomers. It examines R&D investment, heightened competition, and emerging technologies steering market dynamics. Moreover, the report assesses how advancements, product launches, and governmental initiatives impact future market trajectories. It also scrutinizes corporate actions like mergers, acquisitions, and partnerships. Additionally, the report evaluates the efficacy of various strategies in light of evolving technologies, intensifying competition, and shifting consumer demands.
Report Includes:
- 17 data tables and 25 additional tables
- Analysis of the global markets for cell therapy biomanufacturing
- Analyses of global market trends, with market revenue data from 2022, estimates for 2023, forecasts for 2024 and projected CAGRs through 2029
- Estimates of the current market size and revenue prospects, along with a market share analysis by product type, application, end user and region
- Facts and figures pertaining to the market dynamics, technological advances, product launches, regulatory scenarios, and the expected impact of macroeconomic factors
- An analysis of patents and emerging technologies
- Overview of sustainability trends and ESG developments in the industry, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices
An analysis of the industry structure, including companies' market shares, merger and acquisition activity, and venture funding
- Profiles of the leading companies, including Thermo Fisher Scientific Inc., Bristol-Myers Squibb Co., Lonza, Merck KGaA, andBioSenic SA
Product Code: BIO211B
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Cell Therapy
- Stem Cell Transplantation
- Stem Cell Biomanufacturing
- Stem Cell Classification Based on Source
- Stem Cell Classification Based on Ability to Differentiate
- Uses of Stem Cells
- Application of Stem Cells
- Mechanism of Cell Therapy
- Delivery Method of Cell-Based Therapy
Chapter 3 Market Dynamics
- Overview
- Market Drivers
- Rising Prevalence of Chronic and Degenerative Diseases
- Growing Investment in R&D
- Technological Advancements in Bioprocessing
- Expansion of Cell Therapy Manufacturing Infrastructure
- Market Restraints
- Complexity and Cost of Manufacturing
- Supply Chain Issues
- Product Stability and Shelf Life
- Market Opportunities
- Emerging Therapeutic Applications
- Patient-Centric Healthcare Models
Chapter 4 Regulatory Structure
- Regulatory Authorities
- Regulatory Pathways
- Quality Assurance
- Manufacturing Standards
- Global Harmonization Efforts
Chapter 5 Emerging Technologies and Developments
- Newest Technologies/Key Developments
- Advanced Cell Culture Systems
- Genome Editing Technologies
- Bioprocessing Innovation
- Cell Sorting and Purification
- Automation and Robotics
- Data Analytics and Machine Learning
- Tissue Engineering and Organoid Technologies
- Point-of-Care Manufacturing
Chapter 6 Market Segmentation Analysis
- Key Market Trends
- Segmentation Breakdown
- Market Analysis, by Product Type
- Type of Therapy
- Source of Cells
- Market Analysis, by Application
- Skeletal Muscle Repair
- Bone Repair
- Cancer
- Cardiovascular Diseases
- Neurological Disorders
- Other Diseases
- Geographic Breakdown
- Market Analysis, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 7 Competitive Intelligence
- Global Company Ranking
- Strategic Analysis
- M&A and Venture Funding
Chapter 8 Sustainability in Cell Therapy Biomanufacturing: An ESG Perspective
- Environmental Impact
- Supply Chain Sustainability
- Social Responsibility
- Corporate Governance
- Product Lifecycle Management
- Energy and Water
- Recycling
- Process Design and Materials
- Recycling Single-Use Plastics
- Work Environment
Chapter 9 Appendix
- Methodology
- Sources
- Acronyms
- Company Profiles
- BIOSENIC
- BRISTOL-MYERS SQUIBB CO.
- DANAHER CORP.
- IOVANCE BIOTHERAPEUTICS INC.
- LISATA THERAPEUTICS
- LONZA
- MERCK KGAA
- THERMO FISHER SCIENTIFIC INC.
Product Code: BIO211B
List of Tables
- Summary Table A : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029
- Summary Table B : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029
- Table 1 : Global Market for Cell Therapy Biomanufacturing, Through 2029
- Table 2 : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029
- Table 3 : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029
- Table 4 : Global Market for Cell Therapy Biomanufacturing, by Region, Through 2029
- Table 5 : North American Market for Cell Therapy Biomanufacturing, by Country, Through 2029
- Table 6 : European Market for Cell Therapy Biomanufacturing, by Country, Through 2029
- Table 7 : Asia-Pacific Market for Cell Therapy Biomanufacturing, by Country, Through 2029
- Table 8 : RoW Market for Cell Therapy Biomanufacturing, by Country, Through 2029
- Table 9 : Global Market Rankings of Cell Therapy Biomanufacturing, 2023
- Table 10 : Report Sources
- Table 11 : Acronyms Used in Cell Therapy Biomanufacturing Market
- Table 12 : BioSenic: Company Snapshot
- Table 13 : BioSenic: Financial Performance, 2022 and 2023
- Table 14 : BioSenic: Product Portfolio
- Table 15 : Bristol-Myers Squibb Co.: Company Snapshot
- Table 16 : Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023
- Table 17 : Bristol-Myers Squibb Co.: Product Portfolio
- Table 18 : Bristol-Myers Squibb Co.: News/Key Developments, 2024
- Table 19 : Danaher Corp.: Company Snapshot
- Table 20 : Danaher Corp.: Financial Performance, FY 2022 and 2023
- Table 21 : Danaher Corp.: Product Portfolio
- Table 22 : Danaher Corp.: News/Key Developments, 2023
- Table 23 : Iovance Biotherapeutics Inc.: Company Snapshot
- Table 24 : Iovance Biotherapeutics Inc.: Financial Performance, FY 2022 and 2023
- Table 25 : Iovance Biotherapeutics Inc: Product Portfolio
- Table 26 : Iovance Biotherapeutics Inc.: News/Key Developments, 2023
- Table 27 : Lisata Therapeutics: Company Snapshot
- Table 28 : Lisata Therapeutics: Financial Performance, FY 2022 and 2023
- Table 29 : Lisata Therapeutics: Product Portfolio
- Table 30 : Lisata Therapeutics: News/Key Developments, 2022
- Table 31 : Lonza: Company Snapshot
- Table 32 : Lonza Financial Performance, FY 2022 and 2023
- Table 33 : Lonza: Product Portfolio
- Table 34 : Lonza: News/Key Developments, 2023
- Table 35 : Merck KGaA: Company Snapshot
- Table 36 : Merck KGaA: Financial Performance, FY 2022 and 2023
- Table 37 : Merck KgaA: Product Portfolio
- Table 38 : Thermo Fisher Scientific Inc.: Company Snapshot
- Table 39 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
- Table 40 : Thermo Fisher Scientific Inc: Product Portfolio
- Table 41 : Thermo Fisher Scientific Inc: News/Key Developments, 2023
List of Figures
- Summary Figure A : Global Market for Cell Therapy Biomanufacturing, by Product Type, 2021-2029
- Summary Figure B : Global Market for Cell Therapy Biomanufacturing, by Application, 2021-2029
- Figure 1 : Market Dynamics of Cell Therapy Biomanufacturing
- Figure 2 : Global Market Shares of Cell Therapy Biomanufacturing, by Product Type, 2023
- Figure 3 : Global Market Shares of Cell Therapy Biomanufacturing, by Application, 2023
- Figure 4 : Global Market Shares of Cell Therapy Biomanufacturing, by Region, 2023
- Figure 5 : North American Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
- Figure 6 : European Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
- Figure 7 : Asia-Pacific Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
- Figure 8 : RoW Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
- Figure 9 : Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023
- Figure 10 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
- Figure 11 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
- Figure 12 : Lonza: Revenue Share, by Business Unit, FY 2023
- Figure 13 : Lonza: Revenue Share, by Country/Region, FY 2023
- Figure 14 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
- Figure 15 : Merck KgaA: Revenue Share, by Country/Region, FY 2023
- Figure 16 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023
- Figure 17 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.